In a study of human cervical cancer specimens, glucocorticoid receptor (GR) expression was found to be increased in cervical cancer tissues, and OS and progression-free survival were better with high GR expression (Kost et al., 2019). This evidence concerns the gene NR3C1 and cervical carcinoma.